awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48199667-1605B9FA-F6BC-43DA-AF59-7B33A0B79C35
Q48199667-1605B9FA-F6BC-43DA-AF59-7B33A0B79C35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48199667-1605B9FA-F6BC-43DA-AF59-7B33A0B79C35
Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance.
P1476
Q48199667-1605B9FA-F6BC-43DA-AF59-7B33A0B79C35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48199667-1605B9FA-F6BC-43DA-AF59-7B33A0B79C35
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9df59fa24a1e9369af23d4b9f0438c4283d2c26b
P1476
Empagliflozin decreases remnan
......
ients with insulin resistance.
@en